Europe — EMA

Oncotice (Bacillus Calmette-Guérin (Bcg), Tice)

Bacillus Calmette-Guérin (BCG), the active ingredient in Oncotice, is a live attenuated bacterial vaccine presented as an unknown strength/intravitreal form for intravitre use.

Bacillus Calmette-Guérin (Bcg), Tice

Request sourcing

Pack/s

What is Bacillus Calmette-Guérin (Bcg), Tice?

Bacillus Calmette-Guérin (BCG), the active ingredient in Oncotice, is a live attenuated bacterial vaccine presented as an unknown strength/intravitreal form for intravitre use. It treats bladder cancer and is used in oncological settings for immunotherapy. GNH USA supplies Oncotice as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

GNH USA supplies Oncotice as a licensed, GDP‑compliant international pharmaceutical ...

What is Bacillus Calmette-Guérin (Bcg), Tice used for?

Oncotice ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →